253 related articles for article (PubMed ID: 18088504)
1. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
Yang KH; Lee JH; Lee MG
J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
Yang KH; Choi YH; Lee U; Lee JH; Lee MG
J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
[TBL] [Abstract][Full Text] [Related]
3. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
Choi HD; Kang HE; Chung HJ; Bae SK; Shin KN; Lee MG
Biopharm Drug Dispos; 2007 Nov; 28(8):445-54. PubMed ID: 17847127
[TBL] [Abstract][Full Text] [Related]
4. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
Lee DY; Shin HS; Bae SK; Lee MG
Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
Choi YH; Bae SK; Kim SO; Lee MG
Biopharm Drug Dispos; 2007 Mar; 28(2):87-95. PubMed ID: 17230597
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels.
Yang KH; Jung YS; Lee DY; Lee JH; Kim YC; Lee MG
Drug Metab Dispos; 2008 May; 36(5):811-5. PubMed ID: 18308837
[TBL] [Abstract][Full Text] [Related]
8. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
Chung HJ; Choi YH; Kim SH; Lee MG
J Pharm Pharmacol; 2006 Apr; 58(4):449-57. PubMed ID: 16597362
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
[TBL] [Abstract][Full Text] [Related]
10. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats.
Bae SK; Lee SJ; Kim YH; Kim T; Lee MG
J Pharm Pharmacol; 2005 Apr; 57(4):443-52. PubMed ID: 15831204
[TBL] [Abstract][Full Text] [Related]
11. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
Choi YH; Lee MG
Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
Kim EJ; Suh OK; Lee MG
Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
15. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
Chae JW; An JH; Kang W; Ma Jy; Kwon KI
Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
[TBL] [Abstract][Full Text] [Related]
16. The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations.
Bezek S; Kukan M; Pool WF; Woolf TF
Xenobiotica; 1996 Sep; 26(9):935-46. PubMed ID: 8893040
[TBL] [Abstract][Full Text] [Related]
17. Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats.
Chien CF; Wu YT; Lee WC; Lin LC; Tsai TH
Chem Biol Interact; 2010 Mar; 184(3):458-65. PubMed ID: 20096675
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
Han KS; Lee MG
Int J Pharm; 1999 Jul; 184(2):237-42. PubMed ID: 10387953
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
Yang SH; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):853-61. PubMed ID: 18549671
[TBL] [Abstract][Full Text] [Related]
20. The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.
Baskaran R; Shanmugam S; Nagayya-Sriraman S; Kim JH; Jeong TC; Yong CS; Choi HG; Yoo BK
Arch Pharm Res; 2008 Jul; 31(7):938-44. PubMed ID: 18704339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
